Ischemic cardiomyopathy means your heart has weakened specifically because of damage from one or more prior heart attacks, or from chronic reduced blood flow related to coronary artery disease. It's the most common cause of heart failure with reduced ejection fraction in adults, tying together two conditions — coronary disease and heart failure — that need to be managed together, not as separate problems.
What Is Ischemic Cardiomyopathy?
This is heart muscle weakening caused specifically by an "ischemic" source — reduced blood supply from blocked or narrowed coronary arteries — whether from a distinct heart attack or from chronic under-perfusion of heart muscle over time without ever causing a clearly recognized heart attack event.
What's Happening in Your Heart
Heart muscle that loses its blood supply, even briefly, can become permanently scarred if the blood flow isn't restored quickly enough. Scarred muscle doesn't contract, so the remaining healthy muscle has to work harder to compensate, and over time the whole chamber can enlarge and weaken as a compensatory response (the same remodeling process seen in dilated cardiomyopathy generally) that eventually becomes part of the problem itself rather than a helpful adaptation. Not all affected muscle is necessarily dead, though — some muscle can be "hibernating," meaning it's alive but chronically under-supplied and not contracting well, which matters because hibernating muscle can potentially recover function if blood flow is restored, unlike truly scarred tissue.
Types & Causes
Prior heart attack(s) with resulting scar tissue, or chronic coronary artery disease without a single distinct heart attack event — sometimes accumulating gradually as blockages worsen over years. Multiple prior events layering damage over time is common, and it's possible to have significant ischemic cardiomyopathy without ever having had a dramatic, clearly-recognized heart attack, particularly if earlier events were silent or atypical. (See Coronary Artery Disease for the underlying vessel disease itself.)
Common Symptoms
The same pattern seen in heart failure generally, plus possibly ongoing angina if the underlying coronary disease remains active or undertreated — it's worth distinguishing heart-failure-related shortness of breath from angina-type chest discomfort with your care team, since they can point toward different next steps.
How It's Diagnosed
An echocardiogram (assesses overall pumping function), cardiac MRI (which can distinguish scarred from viable "hibernating" muscle using specific imaging techniques — genuinely important for treatment planning, since it helps predict who might benefit from revascularization), and coronary catheterization or CT angiography to directly assess the arteries themselves and determine whether blockages are present that could be treated.
Main Treatment Options
The same four-pillar HFrEF (heart with weak contraction) medications, plus aggressive treatment of the underlying coronary disease — medications to prevent further blockages and clotting, and sometimes revascularization with PCI or CABG if imaging shows there's meaningful viable muscle that could recover blood flow and function — along with strict risk-factor control (blood pressure, cholesterol, diabetes, smoking cessation) to prevent further events, since each additional heart attack causes additional permanent damage. (See Medications 101 and Procedures & Devices.)
Lifestyle Changes That Help
The combined priorities of CAD and HFrEF management — blood pressure, cholesterol, and diabetes control, and smoking cessation — are especially important here, since preventing another event directly protects the heart function you have left, and each preserved bit of function matters. (See Heart-Healthy Eating and Exercise.)
Viability Testing: Deciding Who Benefits from Revascularization
Not every blockage found on catheterization automatically warrants a stent or bypass in someone with ischemic cardiomyopathy — the key question is whether the muscle downstream of that blockage is still "viable" (alive and capable of recovering function) or has already become permanent scar. Viability testing — using cardiac MRI, nuclear imaging, or a dobutamine stress echo — specifically looks for hibernating muscle that could regain function if blood flow is restored, versus scar that wouldn't benefit from the procedure. This distinction genuinely changes the treatment recommendation, which is why it's often assessed before a revascularization decision is finalized rather than assumed from the angiogram alone.
Living With It
Outlook depends heavily on how much muscle is scarred versus viable, and on how well the underlying coronary disease is controlled going forward. This is a condition where preventing the next event is just as important as treating the current one — arguably more so, since scar tissue that's already formed generally doesn't reverse, making prevention of further damage the more actionable lever available.
When to Call Your Doctor vs. Go to the ER
Follows the same pattern as HFrEF, plus: any new chest pain should be taken just as seriously as it would be in someone without heart failure — don't assume it's "just the heart failure," since ongoing coronary disease means a new heart attack remains a real possibility. (See When to Go to the ER vs. Call vs. Wait for a fuller symptom-by-symptom guide.)
Common Questions
Is this different from a regular heart attack?
Ischemic cardiomyopathy is the lasting result of heart attack damage (or chronic reduced blood flow) on the heart's pumping function — distinct from the acute event itself, which is what a heart attack refers to as it's happening.
Will a stent or bypass fix my heart failure?
It may improve function if there's viable, hibernating muscle to restore blood flow to, but it doesn't reverse scar tissue that's already permanently formed — your team will assess this carefully with imaging before recommending a procedure specifically for this reason, rather than assuming any blockage found should automatically be treated.
Why am I on so many medications?
Because you're managing two overlapping conditions — coronary disease and heart failure — at once, each with its own proven therapies, and the combination is what gives you the most complete protection against both further heart attacks and heart failure progression.
What exactly is viability testing checking for?
Whether the heart muscle fed by a blocked artery is still alive and capable of recovering, or is permanent scar — the result directly shapes whether opening that specific blockage is likely to help your pumping function.